Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid-p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate-methyl and tribenuron (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2017/1511
• Articles: 3

Article 1

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2018’;

(2)

in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2018’;

(3)

in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2018’;

(4)

in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2018’;

(5)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2018’;

(6)

in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2018’;

(7)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2018’;

(8)

in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2018’;

(9)

in the sixth column, expiration of approval, of row 101, Chlorothalonil, the date is replaced by ‘31 October 2018’;

(10)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2018’;

(11)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2018’;

(12)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2018’;

(13)

in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2018’;

(14)

in the sixth column, expiration of approval, of row 106, Tribenuron, the date is replaced by ‘31 October 2018’;

(15)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2018’;

(16)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2018’;

(17)

in the sixth column, expiration of approval, of row 117, 1-methylcyclopropene, the date is replaced by ‘31 October 2018’;

(18)

in the sixth column, expiration of approval, of row 118, Forchlorfenuron, the date is replaced by ‘31 October 2018’;

(19)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2018’.